Ganciclovir
- TRADE NAMES: Cymevan; Cymeven; Cymevene; Cytovene (Roche); Vitrasert
- INDICATIONS: Cytomegalovirus retinitis in immunocompromised patients
- CLASS: Antiviral, Guanine nucleoside analog
- HALF-LIFE: 2.5–3.6 hours
CLINICALLY IMPORTANT, POTENTIALLY HAZARDOUS INTERACTIONS WITH:
Abacavir, Amphotericin B, Cobicistat/Elvitegravir/Emtricitabine/Tenofovir Alafenamide, Cobicistat/Elvitegravir/Emtricitabine/Tenofovir Disoproxil, Dapsone, Emtricitabine, Imipenem/Cilastatin, Tenofovir Disoproxil, Zidovudine
PREGNANCY CATEGORY: C
GRANULOCYTOPENIA, ANEMIA AND THROMBOCYTOPENIA
See full prescribing information for complete boxed warning.
Please login to see the rest of this drug profile
SKIN.
HAIR.
MUCOSAL.
CARDIOVASCULAR.
CENTRAL NERVOUS SYSTEM.
ENDOCRINE/METABOLIC.
GASTROINTESTINAL/HEPATIC.
HEMATOLOGIC.
LOCAL.
NEUROMUSCULAR/SKELETAL.
OCULAR.
Page last updated 11/18/2021
Symbol key
Incidence 
- <1%
- 1-5%
- 5-10%
- 10-15%
- 15-20%
- 20-30%
- >30%
Seriousness
- Hospitalization possible
- Life threatening
- Fatal
Warnings in other populations
- Breast feeding
- Geriatric
- Pediatric
